Neuroblastoma: Diagnosis, Therapy, and Prognosis

byM.a. Hayat

Hardcover | November 3, 2011

Neuroblastoma: Diagnosis, Therapy, and Prognosis by M.a. Hayat
$354.95
Earn 1,775 plum® points
Prices and offers may vary in store
Quantity:

In stock online

Ships free on orders over $35

Not available in stores

about

Introduction of new technologies and their applications to neuroblastoma diagnosis, treatment, and therapy assessment are explained. Role of molecular ghenetics in diagnosis and therapy for neuroblastoma patients is detailed. Molecular detection of minimal residual neuroblastoma is described. Magnetic resonance imaging and spectroscopy are detailed for diagnosing this solid, extracranial cancer. Targets for therapeutic intervention in neuroblastoma are identified, including targeting multidrug resistance in this cancer. Ornithine decarboxylase and polyamines are novel targets for therapeutic intervention. The effectiveness of chemotherapy with oral irinotecan and temozolomide is explained. The role of transcription factors (GATA) in neuroblastoma pregression is also included.

Title:Neuroblastoma: Diagnosis, Therapy, and PrognosisFormat:HardcoverProduct dimensions:262 pages, 10 X 7.01 X 0 inShipping dimensions:262 pages, 10 X 7.01 X 0 inPublished:November 3, 2011Publisher:Springer-Verlag/Sci-Tech/TradeLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:9400724179

ISBN - 13:9789400724174

Appropriate for ages: All ages

Look for similar items by category: